1. Home
  2. COLA vs SRTS Comparison

COLA vs SRTS Comparison

Compare COLA & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLA
  • SRTS
  • Stock Information
  • Founded
  • COLA 2024
  • SRTS 2010
  • Country
  • COLA Singapore
  • SRTS United States
  • Employees
  • COLA N/A
  • SRTS N/A
  • Industry
  • COLA
  • SRTS Medical/Dental Instruments
  • Sector
  • COLA
  • SRTS Health Care
  • Exchange
  • COLA NYSE
  • SRTS Nasdaq
  • Market Cap
  • COLA 79.8M
  • SRTS 83.9M
  • IPO Year
  • COLA 2025
  • SRTS 2016
  • Fundamental
  • Price
  • COLA $10.10
  • SRTS $4.71
  • Analyst Decision
  • COLA
  • SRTS Strong Buy
  • Analyst Count
  • COLA 0
  • SRTS 3
  • Target Price
  • COLA N/A
  • SRTS $11.67
  • AVG Volume (30 Days)
  • COLA 13.7K
  • SRTS 57.4K
  • Earning Date
  • COLA 01-01-0001
  • SRTS 08-07-2025
  • Dividend Yield
  • COLA N/A
  • SRTS N/A
  • EPS Growth
  • COLA N/A
  • SRTS N/A
  • EPS
  • COLA N/A
  • SRTS 0.11
  • Revenue
  • COLA N/A
  • SRTS $39,488,000.00
  • Revenue This Year
  • COLA N/A
  • SRTS $4.33
  • Revenue Next Year
  • COLA N/A
  • SRTS $31.55
  • P/E Ratio
  • COLA N/A
  • SRTS $42.87
  • Revenue Growth
  • COLA N/A
  • SRTS 24.75
  • 52 Week Low
  • COLA $9.95
  • SRTS $4.01
  • 52 Week High
  • COLA $10.11
  • SRTS $9.33
  • Technical
  • Relative Strength Index (RSI)
  • COLA N/A
  • SRTS 50.14
  • Support Level
  • COLA N/A
  • SRTS $4.72
  • Resistance Level
  • COLA N/A
  • SRTS $5.02
  • Average True Range (ATR)
  • COLA 0.00
  • SRTS 0.21
  • MACD
  • COLA 0.00
  • SRTS -0.03
  • Stochastic Oscillator
  • COLA 0.00
  • SRTS 27.12

About COLA COLUMBUS ACQUISITION CORP

Columbus Acquisition Corp is a blank check company.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: